Hostname: page-component-7b7567c8c-kwt9d Total loading time: 0 Render date: 2026-11-12T23:01:36.096Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU

Published online by Cambridge University Press:  18 September 2018

Ibukunoluwa C. AkinboyoOpen the ORCID record for Ibukunoluwa C. Akinboyo[Opens in a new window],
Annie Voskertchian,
Gezahegn Gorfu,
Joshua F. Betz,
Tracy L. Ross,
Karen C. Carroll and
Aaron M. Milstone
Ibukunoluwa C. Akinboyo*
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins UniversitySchool of Medicine, Baltimore, Maryland
Annie Voskertchian
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins UniversitySchool of Medicine, Baltimore, Maryland
Gezahegn Gorfu
Affiliation:
Department of Clinical Laboratory Science, College of Nursing and Allied Health Sciences, Howard University, Washington, DC
Joshua F. Betz
Affiliation:
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Tracy L. Ross
Affiliation:
Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland
Karen C. Carroll
Affiliation:
Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland
Aaron M. Milstone
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins UniversitySchool of Medicine, Baltimore, Maryland
*
Author for correspondence: Ibukunoluwa C. Akinboyo, 200 North Wolfe Street, Room 3150, Baltimore, MD 21287. E-mail: ibukun.a@duke.edu
Rights & Permissions [Opens in a new window]

Abstract

Objectives

To examine neonatal risk factors associated with recurrent Staphylococcus aureus colonization and to determine the genetic relatedness of S. aureus strains cultured from neonates before and after decolonization.

Study design

Single-center retrospective cohort study of neonates admitted to the neonatal intensive care unit (NICU) from April 2013 to December 2015, during which weekly nasal cultures from hospitalized NICU patients were routinely obtained for S. aureus surveillance.

Setting

Johns Hopkins Hospital’s 45-bed level IV NICU in Baltimore, Maryland.

Methods

Demographics and clinical data were collected on all neonates admitted to the NICU with S. aureus nasal colonization who underwent mupirocin-based decolonization during the study period. A decolonized neonate was defined as a neonate with ≥1 negative culture after intranasal mupirocin treatment. Pulsed-field gel electrophoresis was used for strain typing.

Results

Of 2,060 infants screened for S. aureus, 271 (13%) were colonized, and 203 of these 271 (75%) received intranasal mupirocin. Of those treated, 162 (80%) had follow-up surveillance cultures, and 63 of these 162 infants (39%) developed recurrent colonization after treatment. The S. aureus strains were often genetically similar before and after decolonization. The presence of an endotracheal tube or nasal cannula/mask was associated with an increased risk of recurrent S. aureus colonization (hazard ratio [HR], 2.65; 95% confidence interval [CI], 1.19–5.90; and HR, 2.21; 95% CI, 1.02–4.75, respectively).

Conclusion

Strains identified before and after decolonization were often genetically similar, and the presence of invasive respiratory devices increased the risk of recurrent S. aureus nasal colonization in neonates. To improve decolonization efficacy, alternative strategies may be needed.

Information

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 11 , November 2018, pp. 1334 - 1339
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Staphylococcus aureus remains the leading cause of pediatric nosocomial infections and a significant threat to hospitalized neonates in the United States.Reference Lake, Weiner, Milstone, Saiman, Magill and See 1 Staphylococcus species, which constitute early components of the neonatal skin, nares and gastrointestinal microbiomes, continue to be responsible for the majority of neonatal late-onset sepsis (LOS).Reference Blanchard, Quach and Autmizguine 2 – Reference Shaw, Sim and Randell 5 Staphylococcus aureus colonization often precedes invasive infections (eg, central-line–associated bloodstream infections (CLABSIs), bacteremia, pneumonia, and on rare occasions meningitis) putting premature infants at risk for long-term neurological sequelae.Reference Stoll, Hansen and Adams-Chapman 4 , Reference Huang, Chou, Su, Lien and Lin 6 – Reference Graham, Morel and Zhou 8

Historically, measures to decrease or eradicate S. aureus colonization, such as treatment with intranasal mupirocin, have focused on methicillin-resistant S. aureus (MRSA). However, rates of methicillin-susceptible S. aureus (MSSA) infections in the neonatal intensive care unit (NICU) outnumber MRSA, and infection-related mortality can be as high as 25% in very low birth weight infants (VLBW, weight <1,500 g).Reference Blanchard, Quach and Autmizguine 2 , Reference Shane, Hansen and Stoll 9 Active surveillance cultures and decolonization of colonized neonates have led to reduced rates of S. aureus transmission and infections,Reference Popoola and Milstone 10 – Reference Pierce, Lessler, Popoola and Milstone 13 an approach that benefits the vulnerable neonate and concurrently, the general NICU population.Reference Popoola, Colantuoni and Suwantarat 11 , Reference Wisgrill, Zizka and Unterasinger 14

Despite the success of decolonization as a strategy to reduce nosocomial infections, hospitalized neonates may develop recurrent S. aureus colonization, which increases the risk for ongoing transmission and infection within the NICU.Reference Delaney, Wang and Melish 12 , Reference Septimus and Schweizer 15 , Reference Abad, Pulia and Safdar 16 A previous study noted that up to half of the decolonized neonates who remain in the NICU for ≥ 21 days may develop recurrent MRSA nasal colonization.Reference Popoola, Budd and Wittig 17 Recurrent S. aureus colonization could be secondary to persistent endogenous reservoirs, environmental reservoirs (eg, healthcare workers, contaminated surfaces, or parents), or may be as a result of antimicrobial resistance.Reference Wisgrill, Zizka and Unterasinger 14 , Reference Lepainteur, Royer and Bourrel 18 , Reference Günther, Blessing, Tacconelli and Mutters 19 No data are available describing factors that may impact the risk of recurrent S. aureus colonization in neonates. In this study, our objectives were to identify neonatal risk factors associated with recurrent S. aureus colonization after decolonization and to examine the genetic relatedness of S. aureus strains before and after decolonization.

Methods

Study design and population

We performed a retrospective cohort study of infants admitted to The Johns Hopkins Hospital’s (JHH) 45-bed NICU from April 2013 to December 2015, a period of active surveillance and decolonization for both MSSA- and MRSA-colonized infants. The NICU has individual patient rooms and 2 separate medical teams with shared nursing staff providing quaternary care to more than 700 infants per year. The Johns Hopkins Institutional Review Board approved the study with a waiver of informed consent.

Case identification and definitions

Using administrative data, all neonates admitted to the NICU during the study period were identified and served as the source population. Microbiology data were collected from a computerized surveillance system (TheraDoc, Premier, Charlotte, NC) and merged with hospital billing data. The study cohort consisted of infants with S. aureus colonization, defined as an infant with 1 or more weekly nasal surveillance culture(s) that grew S. aureus during the initial NICU admission and who received intranasal mupirocin treatment after colonization. A retrospective chart review was conducted to identify clinical characteristics and demographic data at the time of S. aureus colonization. These data were collected and stored on a secure, online database hosted by REDCap.Reference Harris, Taylor, Thielke, Payne, Gonzalez and Conde 20

Neonates with S. aureus nasal colonization underwent decolonization, per hospital protocol, which included a 5-day intranasal mupirocin treatment and topical chlorhexidine (CHG) antisepsis treatment, when age appropriate.Reference Popoola and Milstone 10 During the study period, CHG antisepsis was also part of other concurrent infection prevention bundles in the NICU. Therefore, an infant that received intranasal mupirocin treatment and had at least 1 negative nares surveillance culture after mupirocin treatment was classified as decolonized. The primary study outcome was recurrent colonization after decolonization with mupirocin.

Recurrent colonization was defined as growth of S. aureus from a surveillance culture after decolonization. Microbiological data for S. aureus infections, defined as clinical culture growth from a sterile site, were also collected. Stored bacterial isolates from a subset of infants with recurrent colonization after prolonged nasal clearance (ie, ≥2 negative surveillance cultures prior to recurrence of S. aureus colonization) were used for strain typing.

The following groups of infants were not eligible for the analytic cohort: (1) infants with no subsequent nares cultures after mupirocin treatment, (2) infants whose mupirocin treatments occurred before their first reported positive nares culture, (3) infants who had a subsequent negative surveillance culture prior to mupirocin treatment, and (4) infants with no negative surveillance cultures after decolonization (Fig. 1).

FIG. 1

Flow chart used to identify neonates admitted to the neonatal intensive care unit (NICU) during the study period with Staphylococcus aureus colonization.

Microbiology laboratory methods and bacterial isolate strain typing

All nasal surveillance S. aureus isolates were cultured and distinguished using selective chromogenic agar plates (SaSelect, BioRad, Hercules, CA).Reference Popoola and Milstone 10 , Reference Popoola, Colantuoni and Suwantarat 11 , Reference Totten, Ross, Voskertchian, Colantuoni, Milstone and Carroll 21 Isolates were archived in tryptic soy broth with 20% glycerol at −80°C. As previously described, isolates were characterized by pulsed-field gel electrophoresis (PFGE) using SmaI-digested bacterial DNAReference Tenover, Arbeit and Goering 22 , Reference Tenover, McAllister and Fosheim 23 and were analyzed with a molecular analyst fingerprinting plus software (Fingerprinting II version 3.0, BioRad). They were deemed genetically similar if they had ≤3 band differences (≥85% comparison score).Reference Tenover, Arbeit and Goering 22 Mean comparison scores were measured for bacterial isolates. Gel images were maintained in a password-protected file so that within- and between-run comparisons could be performed for each group of isolates.

Statistical analysis

Continuous variables were summarized by both their means and standard deviations as well as their medians and interquartile ranges (IQRs). Categorical variables were reported as absolute counts and percentages. Kaplan-Meier estimates were calculated from (1) NICU admission to acquisition of S. aureus colonization and (2) S. aureus nasal decolonization to recurrent S. aureus colonization for infants who remained at risk (Fig. 2). Discrete-time Cox proportional hazards were used to explore relationships between clinical factors (methicillin resistance, systemic or topical use of anti-Staphylococci antibiotics (except mupirocin), presence of a peripherally inserted central catheter (PICC), nasoenteric catheter, endotracheal tube, nasal respiratory cannula (or mask), and time (in weeks) from decolonization to recurrent colonization. Discrete-time logistic survival models were also estimated using least-angle shrinkage and selection operator (LASSO) with κ-fold cross validation (κ = 10) to perform shrinkage and variable selection due to the large number of coefficients relative to the sample size and number of events observed.Reference Friedman, Hastie and Tibshirani 24 Analyses were performed using Stata version 14 software (StataCorp, College Station, TX) and R version 3.4.3 software (R Foundation for Statistical Computing, Vienna, Austria).

FIG. 2

Probability of Staphylococcus aureus nasal colonization by birth weight using Kaplan-Meier survival estimates and time from admission to the neonatal intensive care unit (NICU). Note: NICU, neonatal intensive care unit; Btwt, birth weight. Administrative censoring occurred at 14 weeks and 122 neonates did not have birth weights documented.

Results

Acquisition of S. aureus nasal colonization within the NICU

Of the 2,060 infants admitted to the NICU and screened for S. aureus during the study period, 271 (13%) were colonized with S. aureus (Fig. 1). As shown in the Kaplan-Meier analysis (Fig. 2), VLBW infants were significantly more likely to become colonized with S. aureus during NICU admission (log rank test, P = .003). Of the neonates with nasal S. aureus colonization, 203 received mupirocin intranasal treatment, and 167 of the treated infants had subsequent follow-up surveillance cultures. Of the 167 infants, 5 infants with MRSA never cleared S. aureus from surveillance cultures, while 162 infants had at least 1 negative surveillance culture after mupirocin treatment and were included in the analytic cohort. Fewer than 33% of the infants were colonized with MRSA (Table 1).

Table 1

Demographics and Clinical Factors of Mupirocin Treated Neonates With Follow-Up Nasal Staphylococcus aureus Surveillance Cultures

NOTE: SA, Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; WGA, weeks of gestational age; IQR, interquartile range.

a Infants had growth of SA from a nasal surveillance culture and at least 1 negative surveillance culture after mupirocin treatment.

b Infants had at least 1 SA isolate frozen and available for typing before and after nasal mupirocin treatment.

At the time of S. aureus colonization, infants in the cohort were often premature and had been admitted to the NICU for nearly 3 weeks (Table 1). Overall, 133 infants (81.5%) required respiratory support, and 132 (82%) had a nasally placed enteric tube. Nearly half of the infants (48.1%) had a central venous catheter inserted, and 63 infants (38.9%) had received an antibiotic with S. aureus activity (eg, cefazolin, clindamycin, cefepime, or vancomycin) in the week prior to documented growth of S. aureus from surveillance cultures. Clinical characteristics and demographics are summarized in Table 1.

Association between clinical characteristics and time to recurrent colonization

Among the 162 decolonized infants, 63 (39%) had recurrent S. aureus colonization after treatment with intranasal mupirocin (Supplemental Fig. 3). The characteristics of infants with recurrent colonization were similar to the study cohort such that they were mostly premature infants, required respiratory support and/or a nasoenteric tube, and most were colonized with MSSA (Table 1). Using discrete-time Cox proportional hazards models to explore the relationship between clinical risk factors and time to recurrent colonization, we found that the risk of recurrent colonization after mupirocin treatment was higher for neonates with an endotracheal tube or nasal cannula/mask (hazard ratio [HR], 2.65; 95% confidence interval [CI], 1.19–5.90; and HR, 2.21; 95% CI, 1.02–4.75, respectively) (Table 2 and Supplemental Fig. 4). Notably, methicillin resistance (HR, 1.4; 95% CI, 0.59–3.56), recent exposure to anti-S. aureus antibiotics (HR, 0.5; 95% CI, 0.31–1.07), and presence of a central venous catheter (HR, 0.9; 95% CI, 0.5–1.8) at the time of S. aureus colonization were not significantly associated with recurrent colonization after decolonization (Table 2).

Table 2

Discrete-Time Proportional Hazards and Univariate Logistic Regression of Clinical Risk Factors Associated With Staphylococcus aureus Recurrent Colonization After Treatment

Note. SA, Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; CI, confidence interval.

Relatedness between S. aureus strains before and after decolonization

Of the 63 infants with recurrent colonization, 39 (62%) had stored isolates available for strain typing. Of these 39 neonates, 25 (64%) had S. aureus strains that were genetically similar before and after decolonization (mean comparison score, 97.8%; standard deviation [SD], 3.96). Also, 14 neonates (36%) acquired a S. aureus strain that was genetically different from their pre-decolonization strain (mean comparison score, 58.3%; SD, 9.17).

Association between clinical characteristics and recurrent colonization with genetically similar strains

Among the 39 infants with isolates available for strain typing, there was an insignificant increase in the odds of recurrent colonization with concordant strains for those with nasoenteric tubes (odd ratio [OR], 1.43; 95% CI, 0.34–5.83), with nasal cannulas (OR, 1.5; 95% CI, 0.4–5.73) or with exposure to antibiotics in the week prior to S. aureus colonization (OR, 1.78; 95% CI, 0.47– 6.89) (Table 2).

Discussion

Hospitalized neonates are at high risk for invasive S. aureus infections.Reference Lake, Weiner, Milstone, Saiman, Magill and See 1 Decreasing neonatal nasal S. aureus burden, through decolonization, reduces risk of nosocomial infections.Reference Popoola, Colantuoni and Suwantarat 11 In this retrospective study, we demonstrated that >33% of hospitalized neonates developed recurrent S. aureus nasal colonization after a mupirocin-based decolonization treatment. These infants were mostly colonized with genetically similar strains before and after decolonization. Prematurity and respiratory support devices, known risk factors for nosocomial infections,Reference Zingg, Hopkins and Gayet-Ageron 25 were more common in infants with recurrent colonization. To our knowledge, this is the first study reporting NICU-patient level risk factors for S. aureus recurrent colonization and strain similarities before and after decolonization.

Prior studies have associated prolonged inpatient stays, prematurity, and vascular catheterization with S. aureus colonization.Reference Graham, Morel and Zhou 8 , Reference Achermann, Seidl and Kuster 26 – Reference Maraqa, Aigbivbalu and Masnita-Iusan 28 Because premature infants are frequently exposed to endogenous and exogenous reservoirs of S. aureus during extended NICU stays,Reference Milstone, Koontz and Voskertchian 29 we postulated that factors associated with initial colonization may likely affect recurrent colonization. Our study suggests that infants with recurrent colonization were mostly premature, and the risk of recurrence was increased by presence of an endotracheal tube or nasal cannula/mask at the time of S. aureus colonization (Supplemental Fig. 4). These data support the hypothesis that the frequent manipulation of respiratory equipment around the anterior nares or the creation of biofilms may increase the neonatal exposure to S. aureus reservoirs.Reference Zur, Mandell, Gordon, Holzman and Rothschild 30 However, the presence of a vascular catheter and recent systemic exposure to anti-staphylococcal antibiotics, at the time of S. aureus colonization, did not affect time to recurrent colonization.

Although many studies have documented the risk of recurrent colonization after treatment, our study compared the relatedness of strains identified from neonates before and after mupirocin-based decolonization. Our findings suggest that recurrent colonization was largely due to genetically similar strains, which supports prior suggestions that decolonization regimens may attenuate nasal bioburden rather eradicate S. aureus.Reference Wisgrill, Zizka and Unterasinger 14 , Reference Popoola, Budd and Wittig 17 , Reference Gregory, Eichenwald and Puopolo 31 Additionally, extranasal sites of endogenous colonization may contribute to recurrent colonization. However, many hospitals perform nasal surveillance without testing other anatomic sites because the nares remain the principal reservoirs for S. aureus and the elimination of nasal carriage has been associated with decreased incidence of infections.Reference Popoola, Colantuoni and Suwantarat 11 , Reference von Eiff, Becker, Machka, Stammer and Peters 32 Other factors may explain strain similarities before and after decolonization, such as ongoing exposure to a circulating strain within the NICU environment (ie, from HCWs, or re-exposure to a colonized parent).Reference Milstone, Koontz and Voskertchian 29 We did not find clonal S. aureus strains among infants included in the study, suggesting that neonates were not exposed to a common reservoir.

We demonstrated that nasally placed respiratory equipment was associated with a greater risk of recurrent colonization after decolonization. If these findings are replicated, clinicians could consider alternate decolonization strategies or attempt newer methods to eliminate S. aureus reservoirs, such as the use of antibiotic coated respiratory equipment to reduce transmission. Universal decolonization, contact isolation, and systemic antibiotics have been evaluated as alternative decolonization strategies with varying results.Reference Nelson, Bizzarro, Dembry, Baltimore and Gallagher 33 – Reference Jernigan, Titus, Gröschel, Getchell-White and Farr 35 Targeted decolonization for both MSSA and MRSA have not been extensively evaluated in neonates, but in adult patients with high risk of S. aureus infections, targeted decolonization and, at times, mupirocin prophylaxis have proven to be effective strategies.Reference Popoola and Milstone 10 , Reference Delaney, Wang and Melish 12 , Reference Septimus and Schweizer 15 , Reference Schweizer, Chiang and Septimus 36 Future research could identify which of these strategies has the most benefit for neonates. After identifying infants at high risk for recurrent colonization, a systematic approach to rescreening and retreatment with mupirocin may also be beneficial. Questions regarding safety or antimicrobial resistance of mupirocin and CHG are beyond the scope of this study and could be included in future research. Moreover, numerous studies have reported minimal adverse effects or mupirocin resistance after implementation of active surveillance culture and decolonization.Reference Popoola, Colantuoni and Suwantarat 11 , Reference Delaney, Wang and Melish 12 , Reference Wisgrill, Zizka and Unterasinger 14

This study has several limitations. Retrospective data collection and hospital-wide changes in electronic medical record software limited available clinical data. Small sample sizes, weekly S. aureus surveillance, and the single-center study design may have limited the ability to detect differences between groups, the precision of findings, and/or their generalizability. Prospective assessment of risk factors, daily S. aureus surveillance, or multicenter study design may provide findings that are more precise; however, feasibility and costs may be prohibitive. Staphylococcus aureus isolates from infants with recurrent colonization were stored at random and were available at our convenience. Nevertheless, a good proportion (62%) of recolonized infants had available isolates for strain typing. Data regarding CHG use in colonized infants could not be reliably obtained from the medical records. Exposure to CHG may have influenced rates of recurrent colonization, and this could be assessed in future studies. Finally, although PFGE remains the current gold standard for bacteria strain typing, PFGE can have some limitations in assessing genetic relatedness.Reference Tenover, McAllister and Fosheim 23 To further discriminate between isolates, other techniques, such as whole genome sequencing, could be used in future studies.Reference Achermann, Seidl and Kuster 26 , Reference Moore, Cookson and Gordon 37

Staphylococcus aureus colonization is common in the NICU. Neonates with recurrent colonization after mupirocin-based decolonization often have genetically similar strains of S. aureus before and after decolonization. To target neonates at greatest risk for recurrent colonization, clinicians may consider alternate decolonization strategies for premature infants requiring respiratory support equipment.

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/ice.2018.223

Acknowledgments

We would like to acknowledge Danielle Koontz, Marissa Totten, and Dina Khammash for their assistance with data collection and/or bacteria strain typing. We thank the diligent staff of The Johns Hopkins Hospital NICU and The Johns Hopkins Medical Microbiology Laboratory.

Financial support

G.G. was supported by a Howard University Faculty Summer Research Fellowship. Additional funding was provided by Agency for Healthcare Research and Quality (AHRQ grant no. 1R01HS022872), by the National Institutes of Health (NIH training grant no. T32AI052071), and by the Baurenschmidt Foundation.

Conflicts of interest

A.M.M., A.V., and K.C.C. received grant support from The Agency for Healthcare Research and Quality (AHRQ). A.M.M. received prior grant support from Sage Products outside the submitted work. K.C.C. reports other support from GenePOC, GenMark, and Curetis outside the submitted work. All other authors report no conflicts of interest.

References

1. Lake, JG, Weiner, LM, Milstone, AM, Saiman, L, Magill, SS, See, I. Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011–2014. Infect Control Hosp Epidemiol 2018; 39:1–11.Google Scholar
2. Blanchard, AC, Quach, C, Autmizguine, J. Staphylococcal infections in infants: updates and current challenges. Clin Perinatol 2015; 42:119–132.Google Scholar
3. Camacho-Gonzalez, A, Spearman, PW, Stoll, BJ. Neonatal infectious diseases. evaluation of neonatal sepsis. Pediatr Clin North Am 2013;60:367–389.Google Scholar
4. Stoll, BJ, Hansen, NI, Adams-Chapman, I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. J Am Med Assoc 2004;292:2357–2365.Google Scholar
5. Shaw, AG, Sim, K, Randell, P, et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One 2015;10:e0132923.Google Scholar
6. Huang, Y-C, Chou, Y-H, Su, L-H, Lien, R-I, Lin, T-Y. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118:469–474.Google Scholar
7. Milstone, AM, Goldner, BW, Ross, T, Shepard, JW, Carroll, KC, Perl, TM. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011;53:853–859.Google Scholar
8. Graham, PL III, Morel, A-S, Zhou, J, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2002;23:677–682.Google Scholar
9. Shane, AL, Hansen, NI, Stoll, BJ, et al. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012;129:e914–e922.Google Scholar
10. Popoola, VO, Milstone, AM. Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit. J Perinatol 2014;34:805–810.Google Scholar
11. Popoola, VO, Colantuoni, E, Suwantarat, N, et al. Active surveillance cultures and decolonization to reduce Staphylococcus aureus infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2016;37:381–387.Google Scholar
12. Delaney, HM, Wang, E, Melish, M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33:313–318.Google Scholar
13. Pierce, R, Lessler, J, Popoola, VO, Milstone, AM. Meticillin-resistant Staphylococcus aureus (MRSA) acquisition risk in an endemic neonatal intensive care unit with an active surveillance culture and decolonization programme. J Hosp Infect 2017;95:91–97.Google Scholar
14. Wisgrill, L, Zizka, J, Unterasinger, L, et al. Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible Staphylococcus aureus infections in VLBW infants. Neonatology 2017;112:267–273.Google Scholar
15. Septimus, EJ, Schweizer, L. Decolonization in prevention of health care-associated infections. Clin Microbiol 2016;29:201–222.Google Scholar
16. Abad, CL, Pulia, MS, Safdar, N. Does the nose know? An update on MRSA decolonization strategies. Curr Infect Dis Rep 2013;15:455–464.Google Scholar
17. Popoola, VO, Budd, A, Wittig, SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014;35:412–418.Google Scholar
18. Lepainteur, M, Royer, G, Bourrel, AS, et al. Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat? J Hosp Infect 2013;83:333–336.Google Scholar
19. Günther, F, Blessing, B, Tacconelli, E, Mutters, NT. MRSA decolonization failure—are biofilms the missing link? Antimicrob Resist Infect Contro. 2017;6:32.Google Scholar
20. Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.Google Scholar
21. Totten, M, Ross, T, Voskertchian, A, Colantuoni, E, Milstone, AM, Carroll, KC. Analysis of morphologically similar Staphylococcus aureus colonies for assessment of phenotypic and genotypic correlation. J Clin Microbiol 2017;55:2285–2286.Google Scholar
22. Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Guest commentary interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Crite. J Clin Microbiol 1995;33:2233–2239.Google Scholar
23. Tenover, FC, McAllister, S, Fosheim, G, et al. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 2008; 46: 2837–2841.Google Scholar
24. Friedman, J, Hastie, T, Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010;33:1–22.Google Scholar
25. Zingg, W, Hopkins, S, Gayet-Ageron, A, et al. Health-care–associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis 2017;17:381–389.Google Scholar
26. Achermann, Y, Seidl, K, Kuster, SP, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus in a neonatology ward. Infect Control Hosp Epidemiol 2015;36:1305–1312.Google Scholar
27. Washam, M, Woltmann, J, Haberman, B, Haslam, D, Staat, MA. Risk factors for methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: a systematic review and meta-analysis. Am J Infect Control 2017;45:1388–1393.Google Scholar
28. Maraqa, NF, Aigbivbalu, L, Masnita-Iusan, C, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Am J Infect Control 2011;39:35–41.Google Scholar
29. Milstone, AM, Koontz, DW, Voskertchian, A, et al. Treating parents to reduce NICU transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial. BMJ Open 2015;5:e009274–2015-009274.Google Scholar
30. Zur, KB, Mandell, DL, Gordon, RE, Holzman, I, Rothschild, MA. Electron microscopic analysis of biofilm on endotracheal tubes removed from intubated neonates. Otolaryngol Head Neck Surg 2004;130:407–421.Google Scholar
31. Gregory, ML, Eichenwald, EC, Puopolo, KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009;123:e790–e796.Google Scholar
32. von Eiff, C, Becker, K, Machka, K, Stammer, H, Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344:11–16.Google Scholar
33. Nelson, MU, Bizzarro, MJ, Dembry, LM, Baltimore, RS, Gallagher, PG. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol. 2014;34:653–655.Google Scholar
34. Huang, SS, Septimus, E, Kleinman, K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368:2255–2265.Google Scholar
35. Jernigan, J, Titus, M, Gröschel, D, Getchell-White, S, Farr, B. Effectiveness of contact isolation during a hospital outbreak of methicillin- resistant Staphylococcus aureus . Am J Epidemiol 1996;143:496–504.Google Scholar
36. Schweizer, ML, Chiang, H-Y, Septimus, E, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015;313:2162.Google Scholar
37. Moore, G, Cookson, B, Gordon, NC, et al. Whole-genome sequencing in hierarchy with pulsed-field gel electrophoresis: the utility of this approach to establish possible sources of MRSA cross-transmission. J Hosp Infect 2015;90:38–45. doi: 10.1016/j.jhin.2014.12.014 Google Scholar
Figure 0

FIG. 1Flow chart used to identify neonates admitted to the neonatal intensive care unit (NICU) during the study period with Staphylococcus aureus colonization.

Figure 1

FIG. 2Probability of Staphylococcus aureus nasal colonization by birth weight using Kaplan-Meier survival estimates and time from admission to the neonatal intensive care unit (NICU). Note: NICU, neonatal intensive care unit; Btwt, birth weight. Administrative censoring occurred at 14 weeks and 122 neonates did not have birth weights documented.

Figure 2

Table 1Demographics and Clinical Factors of Mupirocin Treated Neonates With Follow-Up Nasal Staphylococcus aureus Surveillance Cultures

Figure 3

Table 2Discrete-Time Proportional Hazards and Univariate Logistic Regression of Clinical Risk Factors Associated With Staphylococcus aureus Recurrent Colonization After Treatment

Supplementary material: File

Akinboyo et al. supplementary material

Akinboyo et al. supplementary material 1

Download Akinboyo et al. supplementary material(File)
File 12.2 KB
Supplementary material: Image

Akinboyo et al. supplementary material

Akinboyo et al. supplementary material 2

Download Akinboyo et al. supplementary material(Image)
Image 48 KB
Supplementary material: Image

Akinboyo et al. supplementary material

Akinboyo et al. supplementary material 3

Download Akinboyo et al. supplementary material(Image)
Image 72.5 KB